Basic Information
CannPal Animal Therapeutics Limited (ASX: CP1) is a listed animal health company dedicated to developing innovative and naturally derived plant-based therapeutic products targeting pets with an endocannabinoid system that owners can trust, ensuring the products are both safe and scientifically validated.The company focuses on cannabinoid research, active pharmaceutical ingredients extracted from the cannabis plant, aiming to provide veterinarians and pet owners with clinically validated and standardized therapies to treat animals in a safe and ethical manner.CannPal has identified a significant opportunity to benefit from the rapidly growing medical cannabis and animal health markets by developing innovative therapies that can influence the cannabinoid system with full regulatory approval from veterinary authorities.